Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib helps hair regrow in some kids with severe alopecia areata, but more research is needed on long-term effects.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

New therapies for Birt–Hogg–Dubé syndrome are being developed based on understanding the FLCN gene's role.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

Some blood pressure medications are linked to a higher risk of skin cancer.

No method fully prevents hair loss from chemotherapy, but some methods can reduce it and improve quality of life.

Boosting certain cell signals can prevent hair loss from chemotherapy and radiation.

Boosting certain cell signals can prevent hair loss from chemotherapy and radiation.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

The inhibitor affects androgen metabolism but not ovarian function.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

Natural products may help treat Non-Small Cell Lung Cancer by causing cancer cell death through ferroptosis.

Docetaxel slightly extends prostate cancer survival but has significant side effects and high cost.

Baricitinib helps treat severe hair loss in people over 65.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Activating certain hair follicle cells could prevent hair loss from cancer treatments.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

Tumor-targeted drug carriers can improve chemotherapy precision and reduce side effects.

KY19382 helps regrow hair and create new hair follicles.

High levels of ODC and a mutant Ha-ras gene cause tumors in mice.

Bioregulatory medicine improved the dog's health and recovery from chemotherapy side effects.

Clinical trials should use innovative designs and biomarkers to improve precision therapy and patient outcomes.

Blocking certain immune signals can reduce skin damage from radiation therapy.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

Injury boosts normal skin cell growth, reducing cancer cell advantage.